골시멘트 : 세계 시장 인사이트, 경쟁 구도 및 시장 예측(-2030년)

Bone Cement Market By Product Type (Polymethyl Methacrylate Cement, Glass Polyalkenoate Cement, And Calcium Phosphate Cement), By Joints (Knee, Hip, Shoulder, Spinal, And Others), By Procedure Type (Arthroplasty, Kyphoplasty, And Vertebroplasty) By End User (Hospital, Ambulatory Surgical Centers, And Others) by geography is estimated to register growth at a steady CAGR forecast during 2024-2030 owing to rising prevalence of osteoporosis and joint replacement surgeries

The global bone cement market was valued at USD 894.86 million in 2023, growing at a CAGR of 5.73% during the forecast period from 2024 to 2030 to reach USD 1,247.31 million by 2030. The bone cement market is anticipated to witness prosperity owing to factors such rising prevalence of osteoporosis which leads to more factures. Furthermore, an increase in joint replacement surgeries over the last decade has fueled the market growth of the bone cement industry. An increase in the geriatric population is another factor that will result in appreciable revenue growth in the bone cement market during the forecast period (2024-2030).

Bone Cement Market Dynamics:

One of the major factors which are driving the bone cement market is the rising prevalence of osteoporosis. It is a condition where the bone density reduces thus making the bone weak. Osteoporosis leads to frequent fractures even from minor falls or coughing and sneezing. The increase in the rate of fractures due to the increasing prevalence of osteoporosis has led to a growth in the bone cement market.

The data published by International Osteoporosis Foundation states that due to the condition more than 8.9 million fractures happen annually worldwide. In 2019, across Europe, 32 million individuals aged 50 are estimated to have osteoporosis, equivalent to 5.6% of the total European population aged 50 and over, or approximately 25.5 million women (22.1% of women aged 50 and above) and 6.5 million men (6.6% of men aged 50 and above). Furthermore, as per the same source, by 2050, the worldwide incidence of hip fracture in men is projected to increase by 310% and 240% in women, compared to rates in 1990.

Thus, the increasing incidences of osteoporosis among men and women are increasing the demand for bone cement, which is anticipated to boost the market's growth over the forecast period from 2024-2030.

Moreover, the increasing geriatric population has further driven the need for bone cement market as due to old age, the chances of getting fractures increase many folds due to weakened muscle strength and fragile bone.

According to WHO, by 2050, the world's population of people aged 60 years and older will double to almost 2.1 billion. The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million, thereby fueling the growth of the bone cement market in the forecast period of 2024-2030.

Furthermore, the increase in joint replacement surgeries over the past few decades has increased the demand for the bone cement market. As per the analysis of the Organisation for Economic Cooperation and Development (OECD), on average, hip replacement rates in OECD countries increased by 22% between 2009 and 2019, and knee replacement rates by 35%. This aligns with the rising incidence and prevalence of osteoarthritis, caused by aging populations and growing obesity rates in OECD countries. Thus, driving the growth of the bone cement market in the forecast period of 2024-2030.

COVID-19 has adversely impacted the bone cement market. Due to social distancing, many hospitals were restricted to perform non-elective procedures and surgeries. Furthermore, during the pandemic, the ICU beds were occupied by COVID-19-affected patients. As per a research study published in 2022 titled "A Nation-Wide Review of Elective Surgery and COVID-Surge Capacity" in 2020, there was a 91% reduction from baseline in the number of elective surgeries performed allowing 78% of surgical ICU beds to be available for COVID-19 positive patients in the US.

Moreover, the number of road accidents also decreased across the globe. For instance, in the US, traffic accidents fell by almost half during the two months at the beginning of the COVID-19 pandemic, when residents of most states were forced to stay at home. Therefore, a decrease in road accidents is an indicator of fewer trauma cases. Thus, such instances indicate that the market witnessed slow growth during the pandemic as bone cement is used in the treatment of accident cases. However, with masses being vaccinated and lockdown restrictions being lifted in most parts of the world, the market is expected to witness normalcy.

There are certain restraining factors to the growth of the bone cement market such as unfavorable reimbursement scenarios and the high cost required for launching new products. These above-mentioned factors will act as barriers that will impact the market growth during the forecast period from 2024-2030.

Bone Cement Market Segment Analysis:

Bone Cement Market by Product Type (Polymethyl Methacrylate Cement, Glass Polyalkenoate Cement, and Calcium Phosphate Cement), by Joints (Knee, Hip, Shoulder, Spinal, and Others), by Procedure Type (Arthroplasty, Kyphoplasty, and Vertebroplasty) by End User (Hospital, Ambulatory Surgical Centers, and Others), Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Based on the procedure type segment of the bone cement market, arthroplasty accounted for the largest market share in the year 2023. This can be ascribed to the increase in arthroplasty procedures lately.

Arthroplasty is a surgical procedure to restore the function of a joint. Commonly, the damaged joint is restored by using artificial joints and bone cement. The increase in the prevalence of osteoporosis is one of the main reasons for to increase in arthroplasty surgeries over the years. Thus, by procedure type segment arthroplasty is estimated to be the largest market share.

Due to advancements in arthroplasty, the procedure volume has increased many folds. According to American Joint Replacement Registry (AJRR) 2022 data, almost 2.4 million hip and knee surgeries from over 1150 institutions submitted data, representing an 18.3% increase in total procedural volume compared with that in 2020. This represents a 40% capture rate of all the US total joint arthroplasty (TJA) volume annually. The 2022 AJRR Annual Report reported 2,244,587 primary and revision hip and knee arthroplasties between 2012 and 2020. The majority of the surgeries were primary total knee arthroplasty (54.5%) and primary total hip arthroplasty (38.6%).

All these increases in arthroplasty surgery numbers correspond to the increased market share of the segment, thereby increasing the market growth for the bone cement market.

North America is expected to dominate the overall Bone Cement Market:

Among all the regions, North America is expected to lead in revenue generation in the global bone cement market. The highest growth in the region is registered due to the reasons such as rising cases of bone degenerative diseases, rising cases of trauma, and the presence of major players in the market.

For instance, as per the report published by the Canadian Institute for Health Information in June 2022, in Canada, around 75,073 knee replacements were performed in 2020. It also reported that knee replacement surgery showed an estimated inpatient cost of approximately USD 10,500, which counts up to more than USD 1.4 billion spent annually on this surgery. Therefore, such an instance indicates considerable market growth in this region.

Furthermore, as per the 2019 study quoted in International Osteoporosis Foundation, based on almost 380,000 fractures in female Medicare beneficiaries, 10% had another fracture within 1 year, 18% within 2 years, and 31% within 5 years in the US.

Apart from this, the presence of many key players in the North American region for the bone cement market is also a key factor for the dominance in the market share.

For instance, Stryker is the leading bone cement manufacturer. It is headquartered in the US. The product advancement in the field of bone cement market by a major player like Stryker is growing the market in the North American region. Such as the Antibiotic Simplex bone cement by Stryker.

Therefore, the above-mentioned factors are expected to bolster the growth of the bone cement market in the North American region during the forecast period of 2024-2030.

Bone Cement Market Key Players:

Some of the key market players operating in the bone cement market include Stryker Corporation, Zimmer Biomet, DePuy Synthes (Johnson & Johnson), Smith & Nephew plc, DJO Global, Arthrex Inc, Exactech, Heraeus Holding, Cardinal Health, Tecres S.p.A., Teknimed, Amplitude, Bioceramed, BM Korea, Linacol Medical and others.

Recent Developmental Activities in the Bone Cement Market:

In July 2022, GRAFTYS SA, a recognized specialist in resorbable bone cement for orthopedic surgery, completed an investment round of 2.0 Million Euros with its existing shareholders to accelerate the commercial development and new product launches.

In May 2022, KPower Bhd's, a subsidiary of Granulab (M) Sdn Bhd, launched Malaysia's first halal-certified synthetic bone cement, Prosteomax. Prosteomax is an innovative synthetic calcium phosphate bone cement that has been certified as halal.

Key Takeaways from the Bone Cement Market Report Study

• Market size analysis for current bone cement market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the bone cement market.
• Top key product developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global bone cement market.
• Various opportunities available for the other competitor in the bone cement market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current bone cement market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for bone cement market growth in the coming future?

Target Audience who can be benefited from this Bone Cement Market Report Study

• Bone cement products providers
• Research organizations and consulting companies
• Bone cement-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in bone cement
• Various distribution channels who want to know more about the bone cement market and the latest product innovations in the bone cement market.

Frequently Asked Questions for Bone Cement Market:

1. What is Bone cement?

Bone cement is a mixture of solid and liquid components that hardens to form a bone-like structure to be used in the human body. It is often used in joint replacement surgeries and internal fixation surgeries. Bone cement was originally developed for dental applications.

2. What is the market for global Bone cement?

The global bone cement market was valued at USD 894.86 million in 2023, growing at a CAGR of 5.73% during the forecast period from 2024 to 2030 to reach USD 1,247.31 million by 2030.

3. What are the drivers for the global Bone cement market?

The bone cement market is anticipated to witness prosperity owing to factors such rising prevalence of osteoporosis which leads to more factures. Furthermore, an increase in joint replacement surgeries over the last decade has fueled the market growth of the bone cement industry. An increase in the geriatric population is another factor that will result in appreciable revenue growth in the bone cement market during the forecast period (2024-2030).

4. Who are the key players operating in the global Bone cement market?

Some of the key market players operating in the bone cement market include Stryker Corporation, Zimmer Biomet, DePuy Synthes (Johnson & Johnson), Smith & Nephew plc, DJO Global, Arthrex Inc, Exactech, Heraeus Holding, Cardinal Health, Tecres S.p.A., Teknimed, Amplitude, Bioceramed, BM Korea, Linacol Medical and others.

5. Which region has the highest share in the Bone cement market?

Among all the regions, North America is expected to lead in revenue generation in the global bone cement market. The highest growth in the region is registered due to the reasons such as rising cases of bone degenerative diseases, rising cases of trauma, and the presence of major players in the market in the region.

Table of Contents

1. Bone Cement Market Report Introduction

2. Bone Cement Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Bone Cement Market Key Factors Analysis

• 3.1. Bone Cement Market Drivers
  • 3.1.1. Rising prevalence of osteoporosis
  • 3.1.2. Increase in joint replacement surgeries
  • 3.1.3. Increase in trauma, accident, and sports-related injuries
  • 3.1.4. Growing geriatric population
• 3.2. Bone Cement Market Restraints and Challenges
  • 3.2.1. Unfavorable reimbursement scenarios
  • 3.2.2. The high cost required for launching a new product
• 3.3. Bone Cement Market Opportunities
  • 3.3.1. Companies adopting various business strategies such as product launches, acquisitions, and partnerships to maintain their market positions

4. Bone Cement Market Porter's Five Forces Analysis

• 4.1. Bargaining Power of Suppliers
• 4.2. Bargaining Power of Consumers
• 4.3. Threat of New Entrants
• 4.4. Threat of Substitutes
• 4.5. Competitive Rivalry

5. COVID-19 Impact Analysis on Bone Cement Market

6. Bone Cement Market Layout

• 6.1. By Product Type
  • 6.1.1. Polymethyl Methacrylate Cement
  • 6.1.2. Glass Polyalkenoate Cement
  • 6.1.3. Calcium Phosphate Cement
• 6.2. By Joints
  • 6.2.1. Knee
  • 6.2.2. Hip
  • 6.2.3. Shoulder
  • 6.2.4. Spine
  • 6.2.5. Others
• 6.3. By Procedure Type
  • 6.3.1. Arthroplasty
  • 6.3.2. Kyphoplasty
  • 6.3.3. Vertebroplasty
• 6.4. By End User
  • 6.4.1. Hospital
  • 6.4.2. Ambulatory Surgical Centers
  • 6.4.3. Others
• 6.5. By Geography
  • 6.5.1. North America
    • 6.5.1.1. United States Bone Cement Market in USD million (2021-2030)
    • 6.5.1.2. Canada Bone Cement Market in USD million (2021-2030)
    • 6.5.1.3. Mexico Bone Cement Market in USD million (2021-2030)
  • 6.5.2. Europe
    • 6.5.2.1. France Bone Cement Market in USD million (2021-2030)
    • 6.5.2.2. Germany Bone Cement Market in USD million (2021-2030)
    • 6.5.2.3. United Kingdom Bone Cement Market in USD million (2021-2030)
    • 6.5.2.4. Italy Bone Cement Market in USD million (2021-2030)
    • 6.5.2.5. Spain Bone Cement Market in USD million (2021-2030)
    • 6.5.2.6. Rest of Europe Bone Cement Market in USD million (2021-2030)
  • 6.5.3. Asia-Pacific
    • 6.5.3.1. China Bone Cement Market in USD million (2021-2030)
    • 6.5.3.2. Japan Bone Cement Market in USD million (2021-2030)
    • 6.5.3.3. India Bone Cement Market in USD million (2021-2030)
    • 6.5.3.4. Australia Bone Cement Market in USD million (2021-2030)
    • 6.5.3.5. South Korea Bone Cement Market in USD million (2021-2030)
    • 6.5.3.6. Rest of the Asia Pacific Bone Cement Market in USD million (2021-2030)
  • 6.5.4. Rest of the World (RoW)
    • 6.5.4.1. Middle East Bone Cement Market in USD million (2021-2030)
    • 6.5.4.2. Africa Bone Cement Market in USD million (2021-2030)
    • 6.5.4.3. South America Bone Cement Market in USD million (2021-2030)

7. Bone Cement Market Company and Product Profiles

• 7.1. Stryker Corporation
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Zimmer Biomet
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. DePuy Synthes (Johnson & Johnson)
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Smith & Nephew plc
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. DJO Global
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Arthrex Inc
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Exactech
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Heraeus Holding
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Cardinal Health
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Tecres S.p.A
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. Teknimed
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Amplitude
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. Bioceramed
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. BM Korea
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. Linacol Medical
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us